AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:AMN - US0017441017 - Common Stock
16.26 USD
-0.31 (-1.87%)
16.26 USD
0 (0%)
Taking everything into account, AMN scores 4 out of 10 in our fundamental rating. AMN was compared to 100 industry peers in the Health Care Providers & Services industry. AMN has an average financial health and profitability rating. AMN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
AMN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years AMN had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -12.88%, AMN is not doing good in the industry: 76.00% of the companies in the same industry are doing better.
AMN has a Return On Equity of -42.76%. This is in the lower half of the industry: AMN underperforms 73.00% of its industry peers.
The Return On Invested Capital of AMN (2.08%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMN is above the industry average of 9.42%.
The last Return On Invested Capital (2.08%) for AMN is well below the 3 year average (13.14%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROIC | 2.08% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
1.3 Margins
The Operating Margin of AMN (1.65%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AMN has declined.
The Gross Margin of AMN (29.37%) is comparable to the rest of the industry.
AMN's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% |
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
2. Health
2.1 Basic Checks
AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMN has been increased compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
Compared to 1 year ago, AMN has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.40 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.40, AMN is in line with its industry, outperforming 52.00% of the companies in the same industry.
AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.80, AMN is in the better half of the industry, outperforming 73.00% of the companies in the same industry.
A Debt/Equity ratio of 1.31 is on the high side and indicates that AMN has dependencies on debt financing.
AMN's Debt to Equity ratio of 1.31 is on the low side compared to the rest of the industry. AMN is outperformed by 66.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Altman-Z | 2.4 |
ROIC/WACC0.27
WACC7.71%
2.3 Liquidity
A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
The Current ratio of AMN (1.05) is worse than 68.00% of its industry peers.
A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
AMN has a Quick ratio of 1.05. This is in the lower half of the industry: AMN underperforms 62.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
Measured over the past 5 years, AMN shows a small growth in Earnings Per Share. The EPS has been growing by 0.80% on average per year.
Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -11.42% in the last year.
The Revenue has been growing slightly by 6.07% on average over the past years.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
3.2 Future
AMN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.82% yearly.
Based on estimates for the next years, AMN will show a small growth in Revenue. The Revenue will grow by 4.40% on average per year.
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 8.60 indicates a reasonable valuation of AMN.
Based on the Price/Earnings ratio, AMN is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 26.49, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 21.06 indicates a rather expensive valuation of AMN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN is on the same level as its industry peers.
AMN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.69.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 21.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 99.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.8 | ||
| EV/EBITDA | 6.89 |
4.3 Compensation for Growth
AMN's earnings are expected to decrease with -29.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)10.69
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
16.26
-0.31 (-1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners108.78%
Inst Owner Change0.2%
Ins Owners0.43%
Ins Owner Change1.64%
Market Cap624.55M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.13 (29.95%)
Short Float %6.73%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)0.69%
PT rev (3m)2.11%
EPS NQ rev (1m)21.46%
EPS NQ rev (3m)30.55%
EPS NY rev (1m)20.88%
EPS NY rev (3m)18.17%
Revenue NQ rev (1m)10.5%
Revenue NQ rev (3m)14.81%
Revenue NY rev (1m)4.59%
Revenue NY rev (3m)4.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.6 | ||
| Fwd PE | 21.06 | ||
| P/S | 0.23 | ||
| P/FCF | 2.8 | ||
| P/OCF | 2.34 | ||
| P/B | 0.97 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.89 |
EPS(TTM)1.89
EY11.62%
EPS(NY)0.77
Fwd EY4.75%
FCF(TTM)5.8
FCFY35.67%
OCF(TTM)6.94
OCFY42.7%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.69
Graham Number26.71
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.88% | ||
| ROE | -42.76% | ||
| ROCE | 2.81% | ||
| ROIC | 2.08% | ||
| ROICexc | 2.16% | ||
| ROICexgc | 6.84% | ||
| OM | 1.65% | ||
| PM (TTM) | N/A | ||
| GM | 29.37% | ||
| FCFM | 8.2% |
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.31 | ||
| Debt/FCF | 3.8 | ||
| Debt/EBITDA | 4.12 | ||
| Cap/Depr | 27.3% | ||
| Cap/Sales | 1.62% | ||
| Interest Coverage | 0.95 | ||
| Cash Conversion | 129.62% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | 2.4 |
F-Score4
WACC7.71%
ROIC/WACC0.27
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-51.7%
EPS Next 3Y-29.55%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.81%
Revenue Next 3Y-3.33%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y21.54%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%
AMN HEALTHCARE SERVICES INC / AMN FAQ
What is the fundamental rating for AMN stock?
ChartMill assigns a fundamental rating of 4 / 10 to AMN.
What is the valuation status of AMN HEALTHCARE SERVICES INC (AMN) stock?
ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.
How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?
AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.
How financially healthy is AMN HEALTHCARE SERVICES INC?
The financial health rating of AMN HEALTHCARE SERVICES INC (AMN) is 4 / 10.